Identification of Intracellular Residues in the Dopamine Transporter Critical for Regulation of Transporter Conformation and Cocaine Binding*
暂无分享,去创建一个
Jonathan A Javitch | Ulrik Gether | J. Javitch | U. Gether | C. Loland | Claus Juul Loland | Charlotta Grånäs | C. Grånäs
[1] G. Rudnick,et al. Permeation and gating residues in serotonin transporter. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[2] J. Javitch,et al. Symmetrical dimer of the human dopamine transporter revealed by cross-linking Cys-306 at the extracellular end of the sixth transmembrane segment , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[3] J. Javitch,et al. Cocaine alters the accessibility of endogenous cysteines in putative extracellular and intracellular loops of the human dopamine transporter. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[4] G. Uhl,et al. Dopamine transporter mutants with cocaine resistance and normal dopamine uptake provide targets for cocaine antagonism. , 2002, Molecular pharmacology.
[5] Jonathan A. Javitch,et al. The Uptake Inhibitors Cocaine and Benztropine Differentially Alter the Conformation of the Human Dopamine Transporter* , 2001, The Journal of Biological Chemistry.
[6] S. Amara,et al. Neurotransmitter transporters: recent progress. , 1993, Annual review of neuroscience.
[7] L. Bryan-Lluka. Neurotransmitter Transporters: Structure, Function and Regulation , 2003 .
[8] U. Gether,et al. Defining Proximity Relationships in the Tertiary Structure of the Dopamine Transporter , 1999, The Journal of Biological Chemistry.
[9] M. Caron,et al. Oligomerization and Trafficking of the Human Dopamine Transporter , 2003, The Journal of Biological Chemistry.
[10] T. Litman,et al. Generation of an activating Zn2+ switch in the dopamine transporter: Mutation of an intracellular tyrosine constitutively alters the conformational equilibrium of the transport cycle , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[11] M. Reith,et al. The role of conserved tryptophan and acidic residues in the human dopamine transporter as characterized by site‐directed mutagenesis , 2001, Journal of neurochemistry.
[12] M. Reith,et al. Dual incorporation of photoaffinity ligands on dopamine transporters implicates proximity of labeled domains. , 2001, Molecular pharmacology.
[13] M. Reith,et al. Structure and function of the dopamine transporter. , 2000, European journal of pharmacology.
[14] H. Weinstein,et al. A Structural Context for Studying Neurotransmitter Transporter Function , 2004 .
[15] George R. Uhl,et al. Dopamine Transporter Transmembrane Domain Polar Mutants: ΔG and ΔΔG Values Implicate Regions Important for Transporter Functions , 2000 .
[16] G. Rudnick,et al. A Conformationally Sensitive Residue on the Cytoplasmic Surface of Serotonin Transporter* , 2001, The Journal of Biological Chemistry.
[17] J. Javitch,et al. N-terminal Truncation of the Dopamine Transporter Abolishes Phorbol Ester- and Substance P Receptor-stimulated Phosphorylation without Impairing Transporter Internalization* , 2003, The Journal of Biological Chemistry.
[18] G. Rudnick,et al. Accessibility and Conformational Coupling in Serotonin Transporter Predicted Internal Domains , 2002, The Journal of Neuroscience.
[19] 宁北芳,et al. 疟原虫var基因转换速率变化导致抗原变异[英]/Paul H, Robert P, Christodoulou Z, et al//Proc Natl Acad Sci U S A , 2005 .
[20] Marc G Caron,et al. Monoamine transporters: from genes to behavior. , 2003, Annual review of pharmacology and toxicology.
[21] K. Fahmy,et al. A conserved carboxylic acid group mediates light-dependent proton uptake and signaling by rhodopsin. , 1994, The Journal of biological chemistry.
[22] G R Uhl,et al. Dopamine transporter proline mutations influence dopamine uptake, cocaine analog recognition, and expression , 2000, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[23] J. Javitch,et al. Amphetamine-induced loss of human dopamine transporter activity: an internalization-dependent and cocaine-sensitive mechanism. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[24] H. Sitte,et al. Oligomerization of the Human Serotonin Transporter and of the Rat GABA Transporter 1 Visualized by Fluorescence Resonance Energy Transfer Microscopy in Living Cells* , 2001, The Journal of Biological Chemistry.
[25] J. Javitch,et al. Zn2+ site engineering at the oligomeric interface of the dopamine transporter , 2002, FEBS letters.
[26] R. Lefkowitz,et al. A mutation-induced activated state of the beta 2-adrenergic receptor. Extending the ternary complex model. , 1993, The Journal of biological chemistry.
[27] H. Feirabend,et al. Preservation and staining of myelinated nerve fibers. , 1998, Methods.
[28] R. Blakely,et al. Biogenic amine transporters: regulation in flux , 2000, Current Opinion in Neurobiology.
[29] U. Gether,et al. The monoamine neurotransmitter transporters: structure, conformational changes and molecular gating. , 2001, Current opinion in drug discovery & development.
[30] H Weinstein,et al. Structural probing of a microdomain in the dopamine transporter by engineering of artificial Zn2+ binding sites. , 2000, Biochemistry.
[31] J. B. Justice,et al. Novel tropane-based irreversible ligands for the dopamine transporter. , 2001, Journal of medicinal chemistry.
[32] H. Gu,et al. Cocaine affinity decreased by mutations of aromatic residue phenylalanine 105 in the transmembrane domain 2 of dopamine transporter. , 2003, Molecular pharmacology.
[33] J. B. Justice,et al. Transport-dependent Accessibility of a Cytoplasmic Loop Cysteine in the Human Dopamine Transporter* , 2000, The Journal of Biological Chemistry.
[34] J. Ballesteros,et al. Activation of the β2-Adrenergic Receptor Involves Disruption of an Ionic Lock between the Cytoplasmic Ends of Transmembrane Segments 3 and 6* , 2001, The Journal of Biological Chemistry.
[35] M. Saraste,et al. FEBS Lett , 2000 .
[36] E. Nielsen,et al. Delineation of an endogenous zinc‐binding site in the human dopamine transporter , 1998, The EMBO journal.
[37] R. Lefkowitz,et al. Constitutive activity of receptors coupled to guanine nucleotide regulatory proteins. , 1993, Trends in pharmacological sciences.
[38] M. Caron,et al. Cloning, pharmacological characterization, and chromosome assignment of the human dopamine transporter. , 1992, Molecular pharmacology.
[39] R. Mark Wightman,et al. Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.
[40] T. Schwartz,et al. Biosynthesis of peptide precursors and protease inhibitors using new constitutive and inducible eukaryotic expression vectors , 1990, FEBS letters.
[41] U. Gether,et al. Residues in the Extracellular Loop 4 Are Critical for Maintaining the Conformational Equilibrium of the γ-Aminobutyric Acid Transporter-1* , 2003, Journal of Biological Chemistry.
[42] T. Schwartz,et al. Stable expression of high affinity NK1 (substance P) and NK2(neurokinin A) receptors but low affinity NK3 (neurokinin B) receptors in transfected CHO cells , 1992, FEBS letters.